These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 15127661)
1. Patents on ice. Stix G Sci Am; 2004 May; 290(5):48. PubMed ID: 15127661 [No Abstract] [Full Text] [Related]
2. Will pharmacogenomics alter the role of patents in drug development? Eisenberg RS Pharmacogenomics; 2002 Sep; 3(5):571-4. PubMed ID: 12223043 [No Abstract] [Full Text] [Related]
3. [Industry of traditional Chinese patent medicine science and technology development and review]. Lu J; Wang F; Yan D; Luo Y; Yang M Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):5-8. PubMed ID: 22741452 [TBL] [Abstract][Full Text] [Related]
4. Landscape of chromatin control element patents: positioning effects in pharmaceutical bioproduction. Palazzoli F; Bire S; Bigot Y; Bonnin-Rouleux F Nat Biotechnol; 2011 Jul; 29(7):593-7. PubMed ID: 21747382 [No Abstract] [Full Text] [Related]
5. Research tool patents: tips for facing a "pay up now or litigate" ultimatum. Gogoris A; Ancona P Nat Biotechnol; 2001 Nov; 19(11):1075-7. PubMed ID: 11689855 [No Abstract] [Full Text] [Related]
8. First round to Amgen in EPO battle. Robertson D Nat Biotechnol; 2000 May; 18(5):483. PubMed ID: 10802602 [No Abstract] [Full Text] [Related]
9. Collaborative research presents special problems for patent seekers. Thorne LW; Ergenzinger ER; Spruill WM Nat Biotechnol; 2004 Jul; 22(7):901-2. PubMed ID: 15229550 [No Abstract] [Full Text] [Related]
10. Pharmacia pilots patent share for HIV drug. Nat Rev Drug Discov; 2003 Apr; 2(4):254. PubMed ID: 12680360 [No Abstract] [Full Text] [Related]
11. "Obvious to try": a proper patentability standard in the pharmaceutical arts? Trask AV Fordham Law Rev; 2008 Apr; 76(5):2625-68. PubMed ID: 18546581 [No Abstract] [Full Text] [Related]
12. Antibacterial agents: patent highlights January to June 2002. Phillips OA; Matowe WC Curr Opin Investig Drugs; 2002 Dec; 3(12):1701-11. PubMed ID: 12528302 [TBL] [Abstract][Full Text] [Related]
13. Web alert. The chemistry of drug design and lead optimization. Cavalla D Curr Opin Drug Discov Devel; 2002 Jul; 5(4):473-4. PubMed ID: 12197305 [No Abstract] [Full Text] [Related]
14. A new patent-based approach for technology mapping in the pharmaceutical domain. Russo D; Montecchi T; Carrara P Pharm Pat Anal; 2013 Sep; 2(5):611-27. PubMed ID: 24237169 [TBL] [Abstract][Full Text] [Related]
15. Patenting medical technology. Noonan WD J Leg Med; 1990 Sep; 11(3):263-319. PubMed ID: 2266323 [No Abstract] [Full Text] [Related]
16. [Issues and perspectives for the development of innovative activities in pharmacy under conditions of a transition period]. Posylkina OV; Timaniuk VN; Gladukh EV Lik Sprava; 2003; (1):106-8. PubMed ID: 12712627 [TBL] [Abstract][Full Text] [Related]
17. [Strategy and core technologies for the secondary development of Chinese patent medicine]. Zhagn BL; Fan XH; Liu Y; Qu HB; Zhang JH; Chegn YY Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(22):3797-800. PubMed ID: 24558853 [TBL] [Abstract][Full Text] [Related]
18. Science and the law. Working through the patent problem. Walsh JP; Cohen WM; Arora A Science; 2003 Feb; 299(5609):1021. PubMed ID: 12586928 [No Abstract] [Full Text] [Related]
19. Design-around biotechnology patents: an analysis of US Federal Circuit decisions shows the possibility of designing around biotechnology patents. Wang SJ Hum Vaccin; 2011 Jan; 7(1):125-8. PubMed ID: 21263222 [TBL] [Abstract][Full Text] [Related]
20. Enzo Biochem v. Gen-Probe: complying with the written description requirement under US patent law. Blaug S; Shuster M; Su H Nat Biotechnol; 2003 Jan; 21(1):97-9. PubMed ID: 12511910 [No Abstract] [Full Text] [Related] [Next] [New Search]